Structure Modification of Ginsenoside Rh(2) and Cytostatic Activity on Cancer Cells

人参皂苷Rh(2)的结构修饰及其对癌细胞的细胞抑制活性

阅读:1

Abstract

Ginsenoside Rh(2) (Rh(2)) is one of the most effective anticancer components extracted from red ginseng, but the poor solubility limits its clinical application. In this paper, ginsenoside Rh(2) was modified with maleimidocaproic acid or maleimidoundecanoic acid with functional groups at both ends. The structures of derivatives were determined by analysis of 1D and 2D nuclear magnetic resonance, Fourier transform infrared, and high-resolution mass spectrometry. Antiproliferative cell experiments showed that Rh(2) modified with maleimidocaproic acid (C-Rh(2)) displayed higher cytostatic activity against different tumor cells compared with Rh(2), while Rh(2) modified with maleimidoundecanoic acid (U-Rh(2)) did not exhibit obvious cytotoxicity. The results suggest that the length of the spacer arm may play an important role in the cytostatic activity of the Rh(2) derivatives.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。